Open access

Exploring longitudinal relationships among Alzheimer's disease biomarkers

B. Saef K. K. Petersen Katherine E. Volluz Yan Li D. Tosun Marta Milà-Alomà Leslie M. Shaw H. Zetterberg J. Dage C. Rubel Kyle Ferber L. Du-Cuny J. Coomaraswamy Michael Baratta Y. Mordashova Z. Saad G. Triana-Baltzer N. Ashton Emily A. Meyers E. Rosenbaugh J. M. Sabandal Anthony W. Bannon William Z. Potter Suzanne E. Schindler

Jul 2026 · Alzheimer's & Dementia · Vol 22 · 0 citations · 52 references

Medicine

Abstract

While most studies of Alzheimer's disease (AD) examine cross‐sectional relationships among biomarkers, longitudinal relationships are also highly relevant.

DOI PubMed Semantic Scholar

Read PDF

Similar papers

Open access Aug 2026

Longitudinal plasma phosphorylated tau217 classification and the association with Alzheimer's disease progression

Longitudinal diagnostic and prognostic validity of plasma phosphorylated tau217 (p‐tau217) in Alzheimer's disease (AD) remains uncertain.

Guo-Yu Lan, Wang Liao, Mingxing Jiang et al. · Alzheimer's & Dementia · 0 citations

Open access Sep 2026

Enhancing early Alzheimer's disease clinical trials through prognostic score covariate adjustment

A prognostic score (PS) summarizes a patient's expected disease progression and can increase the statistical efficiency of clinical trials when included as an analysis covariate.

B. T. Scodari, Roland Brown, Xiao-Tong Jiang et al. · Alzheimer's & Dementia · 0 citations

Open access Sep 2026

Transcriptional risk score for chronic kidney disease: relation to Alzheimer's disease

Although Alzheimer's disease (AD) is prevalent in individuals with chronic kidney disease (CKD), the mechanistic link remains unclear. We assessed the impact of CKD transcriptional risk on AD endophenotypes.

Jung-Min Pyun, Young Ho Park, Jiyun Hwang et al. · Alzheimer's & Dementia · 0 citations

Open access Sep 2026

Digital cognitive phenotyping enhances risk stratification in preclinical Alzheimer's disease

Amyloid positivity does not reliably predict near‐term cognitive decline in preclinical Alzheimer's disease (AD). We tested whether digital cognitive phenotyping improves prognostic precision.

C. Vanderlip, C. Stark · Alzheimer's & Dementia · 0 citations

Open access Aug 2026

Cross‐tissue immune profiling of APOE ε4 reveals early dysregulation in Alzheimer's disease

Apolipoprotein E (APOE) ε4 is the strongest genetic risk factor for late‐onset Alzheimer's disease (AD), but its contribution to disease pathogenesis remains incompletely understood.

A. Shvetcov, Shannon Thomson, Mark E. Graham et al. · Alzheimer's & Dementia · 0 citations

Open access Sep 2026

Associations of transitions in frailty and depressive symptoms with the risk of cardiovascular disease in adults with hypertension: findings from three aging cohorts

Graphical abstract

Yue Dong, Qi-Hang Hu · The Journal of Nutrition, He... · 0 citations